BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31472118)

  • 1. HADHA overexpression disrupts lipid metabolism and inhibits tumor growth in clear cell renal cell carcinoma.
    Liu S; Liu X; Wu F; Zhang X; Zhang H; Gao D; Bi D; Qu H; Ge J; Xu Y; Zhao Z
    Exp Cell Res; 2019 Nov; 384(1):111558. PubMed ID: 31472118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.
    Zhao Z; Lu J; Han L; Wang X; Man Q; Liu S
    Tumour Biol; 2016 Jun; 37(6):8121-30. PubMed ID: 26715271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha, a lipid metabolism enzyme, in Wilms tumor patients.
    Wu X; Feng R; Wang X; Guo F; Liu W
    J Cancer Res Ther; 2021 Nov; 17(5):1281-1285. PubMed ID: 34850779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
    Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
    J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
    Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
    Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
    Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
    Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
    Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
    BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
    Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
    Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism.
    Liu R; Feng Y; Deng Y; Zou Z; Ye J; Cai Z; Zhu X; Liang Y; Lu J; Zhang H; Luo Y; Han Z; Zhuo Y; Xie Q; Hon CT; Liang Y; Wu CL; Zhong W
    J Exp Clin Cancer Res; 2021 Jun; 40(1):188. PubMed ID: 34098990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HAO2 inhibits malignancy of clear cell renal cell carcinoma by promoting lipid catabolic process.
    Xiao W; Wang X; Wang T; Chen B; Xing J
    J Cell Physiol; 2019 Dec; 234(12):23005-23016. PubMed ID: 31127626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma.
    Syafruddin SE; Rodrigues P; Vojtasova E; Patel SA; Zaini MN; Burge J; Warren AY; Stewart GD; Eisen T; Bihary D; Samarajiwa SA; Vanharanta S
    Nat Commun; 2019 Mar; 10(1):1152. PubMed ID: 30858363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEIS1 inhibits clear cell renal cell carcinoma cells proliferation and in vitro invasion or migration.
    Zhu J; Cui L; Xu A; Yin X; Li F; Gao J
    BMC Cancer; 2017 Mar; 17(1):176. PubMed ID: 28270206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation.
    Tao T; Yang X; Zheng J; Feng D; Qin Q; Shi X; Wang Q; Zhao C; Peng Z; Liu H; Jiang WG; He J
    Oncogene; 2017 Nov; 36(44):6119-6131. PubMed ID: 28692056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
    Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
    Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mRNA Expression Signature and Prognostic Analysis of Multiple Fatty Acid Metabolic Enzymes in Clear Cell Renal Cell Carcinoma.
    Zhao Z; Liu Y; Liu Q; Wu F; Liu X; Qu H; Yuan Y; Ge J; Xu Y; Wang H
    J Cancer; 2019; 10(26):6599-6607. PubMed ID: 31777589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.